CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG)

CUSIP: 15117P102

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / COM NEW
Total 13F shares
1,412,247
Share change
+696,862
Total reported value
$27,608,756
Price per share
$19.55
Number of holders
34
Value change
+$14,092,548
Number of buys
24
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 15117P102?
CUSIP 15117P102 identifies CBMG - CELLULAR BIOMEDICINE GROUP I - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG) as of Q2 2018

As of 30 Jun 2018, CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,412,247 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, BRIDGEWAY CAPITAL MANAGEMENT INC, Bank of New York Mellon Corp, MORGAN STANLEY, DEUTSCHE BANK AG\, and SCHWAB CHARLES INVESTMENT MANAGEMENT INC. This page lists 34 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.